Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti-cancer drug developed by Cancer Research UK scientists, have reached $1 billion**.

'Treatment alliance' needed to save more children's lives from cancer

Experts are calling for an urgent change to approaches for treating and researching childhood cancers to continue to save more children.

Cancer Research Technology appoints new chairman to its board of directors

Cancer Research Technology - the commercial arm of Cancer Research UK - today announced the appointment of Peter Chambrй as its new chairman.

Treatment reduces dangerous side effects of cancer treatment in children

Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according...

Researchers identify potential target for brain tumour drug

Researchers believe that a drug that targets the body's immune cells could provide a new treatment for malignant brain tumours.

CRT and ValiRx sign licensing deal to develop prostate cancer treatment

CANCER RESEARCH TECHNOLOGY has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant...

Daisies lead to new leukaemia drug

Scientists could be on their way to creating a new leukaemia therapy extracted from a daisy-like plant, a new report has indicated.

'Impressive' new lung cancer drug revealed

Scientists have identified a new drug which could be used to treat people with small cell lung cancer.

CRT and Bayer Schering Pharma to investigate new therapeutic approach in gynaecological and oncological diseases

CANCER RESEARCH TECHNOLOGY has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments...

Sea sponge drug may extend advanced breast cancer survival

A new drug, based on a natural extract from sea sponge, may help to extend the lives of women with advanced breast cancer, UK scientists have found.